Bayer’s proposed $7.25 billion settlement over Roundup-related claims faces a final approval hearing in Missouri court. A judge is scheduled to evaluate whether the settlement framework meets legal requirements, including how it would resolve pending and future lawsuits.
The proceedings include challenges raised by attorneys for some claimants, who argue the deal structure does not adequately account for the interests of plaintiffs they represent. Quartz reports that the objections focus on whether the settlement terms shortchange clients.
Both outlets frame the case as a pivotal step toward final approval, with the court’s decision determining whether the settlement can move forward. While the coverage centers on the same Missouri court review and the same overall settlement figure, the reporting emphasizes different aspects of the dispute: the nature of the objections and the legal “test” the proposal must pass before becoming final.
